Faraz Ali - Jul 29, 2021 Form 3 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Executive Officer, Director
Signature
/s/Leone Patterson Attorney-in-Fact for Faraz Ali
Stock symbol
TNYA
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3
Date filed
7/29/2021, 05:22 PM
Next filing
Feb 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNYA Stock Option (Right to buy) Jul 29, 2021 Common Stock 425K $0.66 Direct F1
holding TNYA Stock Option (Right to buy) Jul 29, 2021 Common Stock 41.7K $2.70 Direct F2
holding TNYA Stock Option (Right to buy) Jul 29, 2021 Common Stock 417K $5.64 Direct F3
holding TNYA Stock Option (Right to buy) Jul 29, 2021 Common Stock 167K $9.36 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/5th of the shares subject to the option granted on September 6, 2018 became vested and exercisable as of June 27, 2019 and 1/60th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F2 1/48th of the shares subject to the option granted on March 10, 2020 became vested and exercisable as of April 10, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F3 1/48th of the shares subject to the option granted on February 27, 2021 became vested and exercisable as of March 27, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F4 1/48th of the shares subject to the option granted on June 17, 2021 became vested and exercisable as of July 17, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.

Remarks:

Date set forth above represents the effective date of the Issuer's initial public offering.